Antimycobacterial activity of 9-sulfonylated/sulfenylated-6-mercaptopurine derivatives.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2001-07-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-894X(01)00266-9PMID 11425535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bacterial proteases: current therapeutic use and future prospects for the development of new antibiotics

  2001cited by this paper
• The Antifungal Activity of Sulfonylated/Carboxylated Derivatives of Dibenzo-1,4-Dioxine-2-Acetyloxime May Be Due to Inhibition of Lanosterol-14Al-Demethylase

  2000cited by this paper
• 4-toluenesulfonylureido derivatives of amines, amino acids and dipeptides: a novel class of potential antitumor agents.

  2000cited by this paper
• A new class of antituberculosis agents.

  2000cited by this paper
• Protease inhibitors: synthesis of clostridium histolyticum collagenase inhibitors incorporating sulfonyl-L-alanine hydroxamate moieties.

  2000cited by this paper
• Latent Mycobacterium tuberculosis–persistence, patience, and winning by waiting

  2000cited by this paper
• Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.

  2000cited by this paper
• Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.

  2000cited by this paper
• Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.

  2000cited by this paper
• Basis for effective combination cancer chemotherapy with antimetabolites.

  2000cited by this paper
• Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents.

  2000cited by this paper
• Carbonic anhydrase inhibitors--Part 94. 1,3,4-thiadiazole-2-sulfonamidederivatives as antitumor agents?

  2000cited by this paper
• Antifungal activity of silver and zinc complexes of sulfadrug derivatives incorporating arylsulfonylureido moieties.

  2000cited by this paper
• 9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis.

  2000cited by this paper
• Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.

  2000cited by this paper
• New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.

  2000cited by this paper
• Use of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease Previously Intolerant of Azathioprine

  2000cited by this paper
• Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group.

  2000cited by this paper
• Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.

  2000cited by this paper
• Synthesis and in vitro anti-mycobacterium activity of N-alkyl-1, 2-dihydro-2-thioxo-3-pyridinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation.

  2000cited by this paper
• Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation.

  2000cited by this paper
• Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action.

  2000cited by this paper
• Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.

  2000cited by this paper
• Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects.

  2000cited by this paper
• Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents?

  2000cited by this paper
• Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?

  1999cited by this paper
• First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.

  1999cited by this paper
• Recent developments in epidemiology, treatment, and diagnosis of tuberculosis

  1999cited by this paper
• Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids.

  1998cited by this paper
• N-[4-(1,1'-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480.

  1998cited by this paper
• Sulfonylamido derivatives of aminoglutethimide and their copper(II) complexes: a novel class of antifungal compounds

  1997cited by this paper
• Cost-Effectiveness of Prophylaxis for Mycobacterium avium Complex Disease

  1997cited by this paper
• Synthesis of some 2,6-bis(alkylthio)-4-pyridine carboxamides and carboxthioamides and their antimycobacterial and antialgal activity.

  1997cited by this paper
• Mycobacterium tuberculosis: beyond genome sequencing.

  1997cited by this paper
• Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

  1997cited by this paper
• Rational design of novel immunosuppressive drugs: analogues of azathioprine lacking the 6-mercaptopurine substituent retain or have enhanced immunosuppressive effects.

  1996cited by this paper
• Comprehensive Heterocyclic Chemistry IV

  1996cited by this paper
• The purine path to chemotherapy

  1989cited by this paper
• 4.27 – 1,3,4-Thiadiazoles

  1984cited by this paper

• Discovery of 2,9-diaryl-6-carbamoylpurines as a novel class of antitubercular agents.

  2024cites this paper
• Exploring rhodanine linked enamine–carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies

  2024cites this paper
• Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies.

  2024cites this paper
• Study of structurally diverse currently used and recently developed antimycobacterial drugs.

  2023cites this paper
• CanB, a Druggable Cellular Target in Mycobacterium tuberculosis

  2023cites this paper
• 6-Morpholino- and 6-amino-9-sulfonylpurine derivatives. Synthesis, computational analysis, and biological activity

  2021influential citation
• Study of Various Chemically and Structurally Diverse Currently Clinically Used and Recently Developed Antimycobacterial Drugs

  2021cites this paper
• Immunometabolism in human brucellosis: An emerging field of investigation.

  2021cites this paper
• Fragment-based approach to novel bioactive purine derivatives

  2020cites this paper
• Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs

  2019cites this paper
• C5-Morpholinomethylation of N1-sulfonylcytosines by a one-pot microwave assisted Mannich reaction.

  2018cites this paper
• Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies

  2018cites this paper
• Cu(II) Complexes of 4-[(1E)-N-{2-[(Z)-Benzylidene-amino]ethyl}ethanimidoyl]benzene-1,3-diol Schiff Base: Synthesis, Spectroscopic, In-Vitro Antioxidant, Antifungal and Antibacterial Studies

  2018cites this paper
• The data on MIC determination of Mycobacterium tuberculosis against different compounds

  2017cites this paper
• Tuberculostatic Activity of 2-Amino-6-Chloropurine Derivatives

  2017cites this paper
• Design, Synthesis, and Antimycobacterial Activity of Novel Theophylline‐7‐Acetic Acid Derivatives With Amino Acid Moieties

  2016cites this paper
• Synthesis and antimycobacterial activity of N-(2-aminopurin-6-yl) and N-(purin-6-yl) amino acids and dipeptides.

  2016cites this paper
• Anti-tubercular activity of some six membered heterocycle compounds

  2015influential citation
• Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.

  2015cites this paper
• Development of nitroimidazopyrans and nitroimidaoxazoles for tuberculosis chemotherapy

  2014cites this paper
• Theophylline-7-acetic acid derivatives with amino acids as anti-tuberculosis agents.

  2014cites this paper
• 6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents

  2013cites this paper
• 6-Oxo and 6-thio purine analogs as antimycobacterial agents.

  2013cites this paper
• Some Recent Approaches in the Design of Synthetic Antitubercular Agents Containing Five‐Membered Heterocyclic Rings

  2013cites this paper
• Development of new antitubercular drugs containing benz-fused ring system

  2013cites this paper
• A review of antimycobacterial drugs in development.

  2012cites this paper
• Recent Efforts for the Development of Antitubercular Drug Containing Diazine Ring

  2012cites this paper
• Study of clinically used and recently developed antimycobacterial agents

  2012cites this paper
• 6-Chloro-9-(2-nitrophenylsulfonyl)-9H-purine

  2011cites this paper
• Synthesis and antitumor activity of new dihydropyridine thioglycosides and their corresponding dehydrogenated forms.

  2010cites this paper
• Recent advances in the design and synthesis of heterocycles as anti-tubercular agents.

  2010cites this paper
• Reviewofknowledgeforrational designandidentificationof anti-tubercularcompounds

  2009cites this paper
• Original article: NOVEL ACTIVITIES OF 1-ADAMANTYLTHIOPYRIDINES AS ANTIBACTERIALS, ANTIMALARIALS AND ANTICANCERS

  2009cites this paper
• Synthesis and Antimycobacterial Evaluation on Arylsulfonyl and Arylcarbonyl Derivatives of Ofloxacin

  2009cites this paper
• Review of knowledge for rational design and identification of anti-tubercular compounds

  2009cites this paper
• Preparation and in‐vitro Evaluation of 4‐Benzylsulfanylpyridine‐2‐carbohydrazides as Potential Antituberculosis Agents

  2009cites this paper
• Synthesis and in vitro activity of 6-amino-2,9-diarylpurines for Mycobacterium tuberculosis

  2009cites this paper
• Facile One‐Pot Synthesis and Antimycobacterial Evaluation of Pyrazolo[3,4‐d]pyrimidines

  2008cites this paper
• New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections

  2008cites this paper
• Recent developments in antitubercular drugs.

  2008cites this paper
• Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compounds.

  2008cites this paper
• Synthesis and Antituberculosis Activity of New Hydrazide Derivatives

  2008cites this paper
• Development of new antituberculous agents based on new drug targets and structure–activity relationship

  2008cites this paper
• Antimicrobial and antioxidative activities of 1-adamantylthio derivatives of 3-substituted pyridines

  2008cites this paper
• Emerging trends in tuberculosis therapy : A review

  2007cites this paper
• Anti-mycobacterial activity of a bis-sulfonamide.

  2007cites this paper
• Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.

  2007cites this paper
• Tuberculosis chemotherapy: recent developments and future perspectives.

  2007cites this paper
• New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents.

  2007cites this paper
• Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines.

  2005cites this paper
• Fighting tuberculosis: An old disease with new challenges

  2005cites this paper
• New Small-Molecule Synthetic Antimycobacterials

  2005cites this paper
• Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives

  2005cites this paper
• Antituberculosis Compounds Under Investigation

  2005cites this paper
• Antimycobacterial agents. 1. Thio analogues of purine.

  2004cites this paper
• Intact Purine Biosynthesis Pathways Are Required for Wild-Type Virulence of Brucella abortus 2308 in the BALB/c Mouse Model

  2004cites this paper
• Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.

  2004cites this paper
• Synthesis and Antimycobacterial Activity of Pyridylmethylsulfanyl and Naphthylmethylsulfanyl Derivatives of Benzazoles, 1, 2, 4‐Triazole, and Pyridine‐2‐carbothioamide/‐2‐carbonitrile

  2004cites this paper
• Identification of Secondary Mutations Which Enhance and Stabilize the Attenuation of Brucella HTRA Mutants: Improving Brucella HTRS-Based Strains as Vaccine

  2003cites this paper
• Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines.

  2002cites this paper
• Antimycobacterial Activity of 9‐Sulfonylated/Sulfenylated‐6‐mercaptopurine Derivatives.

  2001cites this paper
• Antimycobacterial Activity of 3,4-dichlorophenyl-ureas, N,N-diphenyl-ureas and Related Derivatives

  2001cites this paper